导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.95% | 3467/4773 |
| 近一周 | -1.68% | 647/5462 |
| 近一月 | -2.29% | 1230/5421 |
| 近一季 | -5.34% | 1816/5209 |
| 近半年 | -3.52% | 2231/4920 |
| 近一年 | -7.02% | 3208/4366 |
| 近两年 | 40.79% | 1854/2954 |
| 近三年 | 30.17% | 1050/2253 |
| 成立以来 | 17.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.59% 4239/4961 |
7.20% 2737/5312 |
- - |
- - |
| 2025 | 23.57% 1862/4813 |
5.22% 807/3635 |
2.23% 1732/4076 |
18.60% 2274/4524 |
-3.14% 3253/4813 |
| 2024 | 20.09% 489/3463 |
0.30% 1003/2808 |
2.59% 337/3014 |
19.40% 850/3129 |
-2.25% 2019/3463 |
| 2023 | -10.64% 1318/2656 |
1.56% 1551/2280 |
-1.61% 505/2385 |
-5.78% 1375/2515 |
-5.08% 1252/2655 |
| 2022 | -20.50% 976/2207 |
-15.61% 1053/1919 |
5.30% 924/2016 |
-16.86% 1513/2113 |
7.61% 298/2208 |
| 2021 | -9.68% 1081/1822 |
-2.83% 713/1255 |
1.71% 1038/1330 |
-9.92% 1200/1466 |
1.45% 926/1822 |
| 2020 | 26.06% 608/1250 |
-11.76% 852/1028 |
18.38% 339/1067 |
7.49% 776/1164 |
12.27% 486/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 工银湾创100ETF联接A VS. 长安沪深300非周期A(740101) |